市場調査レポート
商品コード
1316744

間葉系幹細胞市場:タイプ、適応症、分離源、用途別-2023~2030年の世界予測

Mesenchymal Stem Cells Market by Type, Indication, Source of Isolation, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
間葉系幹細胞市場:タイプ、適応症、分離源、用途別-2023~2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

間葉系幹細胞の世界市場は、2023年に35億1,338万米ドル、CAGR13.61%で大きく成長し、2030年には85億9,697万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の間葉系幹細胞市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.間葉系幹細胞の世界市場規模および予測は?

2.予測期間中、世界の間葉系幹細胞市場を形成するCOVID-19の阻害要因と影響は?

3.間葉系幹細胞の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は?

4.間葉系幹細胞の世界市場における競争戦略は?

5.間葉系幹細胞の世界市場における技術動向と規制の枠組みは?

6.間葉系幹細胞の世界市場における主要ベンダーの市場シェアは?

7.間葉系幹細胞の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 間葉系幹細胞に基づく研究の拡大
      • 高齢者人口の増加と慢性疾患の増加
      • 進化し続ける幹細胞療法の情勢
    • 抑制要因
      • 幹細胞療法の標準化および規制された提供の欠如
    • 機会
      • 間葉系幹細胞の新たな用途
      • コラボレーションとパートナーシップを拡大し、間葉系幹細胞製品の治療革新を推進
    • 課題
      • ヒトMSC療法に関連する倫理的および安全性の問題
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 間葉系幹細胞市場:タイプ別

  • イントロダクション
  • 同種異系
  • 自己由来

第7章 間葉系幹細胞市場:適応症別

  • イントロダクション
  • 骨と軟骨の修復
  • がん
  • 循環器疾患
  • GvHD
  • 炎症性疾患および免疫疾患
  • 肝臓病

第8章 間葉系幹細胞市場:分離源別

  • イントロダクション
  • 脂肪組織
  • 骨髄
  • 臍帯血
  • 卵管
  • 胎児肝臓
  • 末梢血

第9章 間葉系幹細胞市場:用途別

  • イントロダクション
  • 疾患モデリング
  • 創薬と発見
  • 幹細胞バンク
  • ヒト組織工学
  • 毒物学研究

第10章 南北アメリカの間葉系幹細胞市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の間葉系幹細胞市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの間葉系幹細胞市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. MESENCHYMAL STEM CELLS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2022 VS 2030 (%)
  • FIGURE 7. MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. MESENCHYMAL STEM CELLS MARKET DYNAMICS
  • FIGURE 10. MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY & IMMUNOLOGICAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 15. MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 197. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 198. MESENCHYMAL STEM CELLS MARKET LICENSE & PRICING
目次
Product Code: MRR-B973EDD5ED83

The Global Mesenchymal Stem Cells Market is forecasted to grow significantly, with a projected USD 3,513.38 million in 2023 at a CAGR of 13.61% and expected to reach a staggering USD 8,596.97 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Mesenchymal Stem Cells Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Mesenchymal Stem Cells Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Allogeneic and Autologous. The Allogeneic commanded largest market share of 63.52% in 2022, followed by Autologous.

Based on Indication, market is studied across Bone & Cartilage Repair, Cancer, Cardiovascular Disease, GvHD, Inflammatory & Immunological Disease, and Liver Diseases. The Cancer commanded largest market share of 22.91% in 2022, followed by Cardiovascular Disease.

Based on Source of Isolation, market is studied across Adipose Tissues, Bone Marrow, Cord Blood, Fallopian Tube, Fetal Liver, Lung, and Peripheral Blood. The Bone Marrow commanded largest market share of 23.88% in 2022, followed by Cord Blood.

Based on Application, market is studied across Disease Modeling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, and Toxicology Studies. The Drug Development & Discovery commanded largest market share of 23.20% in 2022, followed by Stem Cell Banking.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.20% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Mesenchymal Stem Cells Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Mesenchymal Stem Cells Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Mesenchymal Stem Cells Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Mesenchymal Stem Cells Market?

4. What is the competitive strategic window for opportunities in the Global Mesenchymal Stem Cells Market?

5. What are the technology trends and regulatory frameworks in the Global Mesenchymal Stem Cells Market?

6. What is the market share of the leading vendors in the Global Mesenchymal Stem Cells Market?

7. What modes and strategic moves are considered suitable for entering the Global Mesenchymal Stem Cells Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Mesenchymal Stem Cells Market, by Type, 2022 vs 2030
  • 4.3. Mesenchymal Stem Cells Market, by Indication, 2022 vs 2030
  • 4.4. Mesenchymal Stem Cells Market, by Source of Isolation, 2022 vs 2030
  • 4.5. Mesenchymal Stem Cells Market, by Application, 2022 vs 2030
  • 4.6. Mesenchymal Stem Cells Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in Mesenchymal Stem Cell-Based Research
      • 5.1.1.2. Rising Geriatric Population Coupled with Growth in Chronic Diseases
      • 5.1.1.3. Continuously Evolving Landscape of Stem Cell Therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Standardized and Regulated Delivery of Stem Cell Therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Applications of Mesenchymal Stem Cells
      • 5.1.3.2. Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical & Safety Issues Associated with Human MSC Therapy
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Mesenchymal Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Allogeneic
  • 6.3. Autologous

7. Mesenchymal Stem Cells Market, by Indication

  • 7.1. Introduction
  • 7.2. Bone & Cartilage Repair
  • 7.3. Cancer
  • 7.4. Cardiovascular Disease
  • 7.5. GvHD
  • 7.6. Inflammatory & Immunological Disease
  • 7.7. Liver Diseases

8. Mesenchymal Stem Cells Market, by Source of Isolation

  • 8.1. Introduction
  • 8.2. Adipose Tissues
  • 8.3. Bone Marrow
  • 8.4. Cord Blood
  • 8.5. Fallopian Tube
  • 8.6. Fetal Liver
  • 8.7. Lung
  • 8.8. Peripheral Blood

9. Mesenchymal Stem Cells Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Modeling
  • 9.3. Drug Development & Discovery
  • 9.4. Stem Cell Banking
  • 9.5. Tissue Engineering
  • 9.6. Toxicology Studies

10. Americas Mesenchymal Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mesenchymal Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Mesenchymal Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing